EUVIMEDEUVIMED entdecken
Multizentrische Studie

Physician Modified Fenestrated Endografts for Endovascular Aortic Arch Repair in Zone 0

Qinshu Wen, Yepeng Zhang, Jun Wei, Mingyang Shen, Guangyan Wu, Xiaolong Du, Xiaoqiang Li, Min Zhou

European Journal of Vascular and Endovascular Surgery · 2024-08 · 68 (2) · 190-199

DOI: 10.1016/j.ejvs.2024.04.008 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2024-08. Verfasst von Qinshu Wen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Aortic Aneurysm, Thoracic, Aortic Dissection, Blood Vessel Prosthesis, Blood Vessel Prosthesis Implantation. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This multicentre study aimed to assess the early and midterm outcomes of physician modified fenestrated endografts (PMEGs) for endovascular aortic arch repair in zone 0. METHODS: Between 2018 and 2022, a retrospective study was conducted in three centres of consecutive patients undergoing endovascular aortic arch repair in zone 0 with PMEGs. Endpoints included technical success, 30 day mortality rate, major adverse events, secondary interventions, stent stability, target vessel patency, and overall survival. RESULTS: A total of 54 patients (mean age 63 years; 45 males) with aortic arch pathology were included, comprising aortic dissections (n = 32; 59%) and aortic arch aneurysms (n = 22; 41%). Technical success was 98%. One patient died from stroke within 30 days. Major adverse events included stroke (n = 4; 7%), retrograde type A dissection (RTAD) (n = 3; 6%), and acute kidney injury (n = 2; 4%). During a median follow up of 12 months, there were two deaths (4%) of unknown cause at one month and 1.5 months, and no aortic related death. Type Ia, type Ic, and type IIIc endoleaks were observed in two (4%), three (6%), and two (4%) patients, respectively. No vessel stenosis was observed. Re-intervention was required in 10 patients (19%). Estimates of overall survival, freedom from secondary intervention, and freedom from target vessel instability at one year were 94.2% (standard error [SE] 3.3%), 81.8% (SE 6.0%), and 92.0% (SE 4.5%), respectively. CONCLUSION: This study has demonstrated the efficacy of PMEGs for zone 0 endovascular aortic arch repair, with acceptable technical success and mortality rates. Stroke, RTAD, and re-intervention rates remain a concern for endovascular therapy. A larger population and long term outcomes are required to assess the safety and durability of this technique as a beneficial choice for endovascular aortic arch repair in specialised centres.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Aneurysm, ThoracicAortic DissectionBlood Vessel ProsthesisBlood Vessel Prosthesis ImplantationEndovascular ProceduresAgedFemaleHumansMaleMiddle AgedAorta, ThoracicPostoperative ComplicationsProsthesis DesignRetrospective StudiesStentsTime FactorsTreatment Outcome

Stichwörter der Autor:innen

Aortic archAortic arch pathologyEndovascular aortic arch repairPhysician modified endograftZone 0

Autor:innen und Institutionen

  • Department of Vascular Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Department of Cardiac Surgery, the First Affiliated Hospital of Wannan Medical College, Wuhu, China.
  • Department of Vascular Surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, China; Department of Vascular Surgery, the Affiliated Huaian No. 1 People's Hospital of Nanjing Medic…
  • Department of Vascular Surgery, Medical School of Southeast University, Nanjing Drum Tower Hospital, Nanjing, China.
  • Department of Vascular Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China; Department of Vascular Surgery, Nanjing Drum Tower Hospital, Clinical College of Na…

Zitieren

APA

Wen, Q., Zhang, Y., Wei, J., Shen, M., Wu, G., Du, X., Li, X., & Zhou, M. (2024). Physician Modified Fenestrated Endografts for Endovascular Aortic Arch Repair in Zone 0. European Journal of Vascular and Endovascular Surgery, 68(2), 190-199. https://doi.org/10.1016/j.ejvs.2024.04.008

Vancouver

Wen Q, Zhang Y, Wei J, Shen M, Wu G, Du X, et al. Physician Modified Fenestrated Endografts for Endovascular Aortic Arch Repair in Zone 0. European Journal of Vascular and Endovascular Surgery. 2024;68(2):190-199. doi:10.1016/j.ejvs.2024.04.008

BibTeX
@article{Wen2024,
  author = {Wen, Qinshu and Zhang, Yepeng and Wei, Jun and Shen, Mingyang and Wu, Guangyan and Du, Xiaolong and Li, Xiaoqiang and Zhou, Min},
  title = {Physician Modified Fenestrated Endografts for Endovascular Aortic Arch Repair in Zone 0},
  journal = {European Journal of Vascular and Endovascular Surgery},
  year = {2024},
  volume = {68},
  number = {2},
  pages = {190--199},
  doi = {10.1016/j.ejvs.2024.04.008}
}
Kostenlos starten →